DUBLIN--(BUSINESS WIRE)-- Covidien (COV) (NYSE: COV), a leading global provider of healthcare products, today announced it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin regular way trading on the New York Stock Exchange today under the symbol "MNK." The distribution of Mallinckrodt ordinary shares occurred on June 28, 2013. In the distribution, Mallinckrodt issued one ordinary share for every eight Covidien ordinary shares held as of the close of business on June 19, 2013, the record date for the distribution. Covidien announced in December 2011 that it planned to spin-off the...
↧